NetworkNewsBreaks – Youngevity International Inc
Post# of 174
(Total Views: 119)
Posted On: 08/26/2019 3:44:25 PM
NetworkNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries Leases State- of-the-Art, Florida Based Hemp Processing and Manufacturing Facility
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, through its wholly owned subsidiary, Khrysos Industries, Inc., today announced that it has leased 82,000 square feet in Orlando, Florida to house its facility for post processing hemp derived products and finished goods manufacturing. The state-of-the-art facility features a 46,200 square foot production area and is the former home of Nephron Pharmaceuticals GMP Certified sterile manufacturing operations. “We believe this facility provides us the opportunity to accelerate our post processing and manufacturing capabilities by approximately two years in terms of production output. The amenities and the infrastructure within the facility saves us significant CAPEX expense, and, more importantly, provides us the ability to grow more rapidly to meet market demand,” Khrysos President Dwayne Dundore, PhD, said in the news release. “We are in the process of moving over our post processing equipment and the extensive power systems in this facility allows us to scale as needed. We expect post processing to be up and running in September and we will then set up our finished product manufacturing lines.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, through its wholly owned subsidiary, Khrysos Industries, Inc., today announced that it has leased 82,000 square feet in Orlando, Florida to house its facility for post processing hemp derived products and finished goods manufacturing. The state-of-the-art facility features a 46,200 square foot production area and is the former home of Nephron Pharmaceuticals GMP Certified sterile manufacturing operations. “We believe this facility provides us the opportunity to accelerate our post processing and manufacturing capabilities by approximately two years in terms of production output. The amenities and the infrastructure within the facility saves us significant CAPEX expense, and, more importantly, provides us the ability to grow more rapidly to meet market demand,” Khrysos President Dwayne Dundore, PhD, said in the news release. “We are in the process of moving over our post processing equipment and the extensive power systems in this facility allows us to scale as needed. We expect post processing to be up and running in September and we will then set up our finished product manufacturing lines.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Youngevity International Inc. (YGYI) Stock Research Links
Scroll down for more posts ▼